[Results of cooperative clinical studies of the antineoplastic antibiotic dactinomycin].
D000293:Adolescent; D000328:Adult; D001859:Bone Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D002648:Child; D002675:Child, Preschool; D002822:Choriocarcinoma / Q000188:drug therapy; D003609:Dactinomycin / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D007223:Infant; D007822:Laryngeal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D008175:Lung Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008297:Male; D008545:Melanoma / Q000188:drug therapy / Q000532:radiotherapy; D008875:Middle Aged; D011247:Pregnancy; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy; D014594:Uterine Neoplasms / Q000188:drug therapy; D009396:Wilms Tumor / Q000188:drug therapy
D003609:Dactinomycin
Rezul'taty kooperirovannogo klinicheskogo izucheniia protivoopukholevogo antibiotika daktinomitsina.